SILO PE Ratio & Valuation, Is SILO Overvalued

Historical Valuation

Silo Pharma Inc (SILO) is now in the Fair zone, suggesting that its current forward PS ratio of 62.08 is considered Fairly compared with the five-year average of -1.26. The fair price of Silo Pharma Inc (SILO) is between 0.06 to 0.39 according to relative valuation method.

Relative Value

Fair Zone

0.06-0.39

Current Price：0.31

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Silo Pharma Inc (SILO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Silo Pharma Inc (SILO) has a current Price-to-Book (P/B) ratio of 0.70. Compared to its 3-year average P/B ratio of 0.84, the current P/B ratio is approximately -16.38% higher. Relative to its 5-year average P/B ratio of 1.73, the current P/B ratio is about -59.55% higher. Silo Pharma Inc (SILO) has a Forward Free Cash Flow (FCF) yield of approximately -107.36%. Compared to its 3-year average FCF yield of -72.22%, the current FCF yield is approximately 48.65% lower. Relative to its 5-year average FCF yield of -49.40%, the current FCF yield is about 117.32% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for SILO competitors is 22.19, providing a benchmark for relative valuation. Silo Pharma Inc Corp (SILO.O) exhibits a P/S ratio of 62.08, which is 179.8% above the industry average. Given its robust revenue growth of 0.00%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of SILO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of SILO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is SILO currently overvalued or undervalued?

What is Silo Pharma Inc (SILO) fair value?

SILO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Silo Pharma Inc (SILO) is between 0.06 to 0.39 according to relative valuation method.

How does SILO's valuation metrics compare to the industry average?

The average P/S ratio for SILO's competitors is 22.19, providing a benchmark for relative valuation. Silo Pharma Inc Corp (SILO) exhibits a P/S ratio of 62.08, which is 179.80% above the industry average. Given its robust revenue growth of 0.00%, this premium appears unsustainable.

What is the current P/B ratio for Silo Pharma Inc (SILO) as of Mar 10 2026?

As of Mar 10 2026, Silo Pharma Inc (SILO) has a P/B ratio of 0.70. This indicates that the market values SILO at 0.70 times its book value.

What is the current FCF Yield for Silo Pharma Inc (SILO) as of Mar 10 2026?

As of Mar 10 2026, Silo Pharma Inc (SILO) has a FCF Yield of -107.36%. This means that for every dollar of Silo Pharma Inc's market capitalization, the company generates -107.36 cents in free cash flow.

What is the current Forward P/E ratio for Silo Pharma Inc (SILO) as of Mar 10 2026?

As of Mar 10 2026, Silo Pharma Inc (SILO) has a Forward P/E ratio of -0.48. This means the market is willing to pay $-0.48 for every dollar of Silo Pharma Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Silo Pharma Inc (SILO) as of Mar 10 2026?

As of Mar 10 2026, Silo Pharma Inc (SILO) has a Forward P/S ratio of 62.08. This means the market is valuing SILO at $62.08 for every dollar of expected revenue over the next 12 months.

SILO Valuation